Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.69 USD | +0.81% | +2.70% | -36.83% |
04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
824M | - | |||||
103B | ||||||
95.28B | ||||||
22.15B | - | |||||
21.02B | - | |||||
18.15B |